{"id":"https://openalex.org/W4387950671","doi":"https://doi.org/10.1177/10600280231205490","title":"Risk of Pancreatitis With Incretin Therapies Versus Thiazolidinediones in the Veterans Health Administration","display_name":"Risk of Pancreatitis With Incretin Therapies Versus Thiazolidinediones in the Veterans Health Administration","publication_year":2023,"publication_date":"2023-10-26","ids":{"openalex":"https://openalex.org/W4387950671","doi":"https://doi.org/10.1177/10600280231205490","pmid":"https://pubmed.ncbi.nlm.nih.gov/37881914"},"language":"en","primary_location":{"id":"doi:10.1177/10600280231205490","doi":"https://doi.org/10.1177/10600280231205490","is_oa":false,"landing_page_url":"https://doi.org/10.1177/10600280231205490","pdf_url":null,"source":{"id":"https://openalex.org/S113426163","display_name":"Annals of Pharmacotherapy","issn_l":"0012-6578","issn":["0012-6578","1060-0280","1542-6270"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of Pharmacotherapy","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5017136592","display_name":"Kristen Wilhite","orcid":"https://orcid.org/0000-0003-1550-6509","observed_orcids":["https://orcid.org/0000-0003-1550-6509"]},"institutions":[{"id":"https://openalex.org/I2799886695","display_name":"Veterans Health Administration","ror":"https://ror.org/05eq41471","country_code":"US","type":"government","lineage":["https://openalex.org/I1322918889","https://openalex.org/I2799886695"]},{"id":"https://openalex.org/I4210111273","display_name":"Louisville VA Medical Center","ror":"https://ror.org/01zd7yk57","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1322918889","https://openalex.org/I2799886695","https://openalex.org/I4210111273","https://openalex.org/I4210112672"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Kristen Wilhite","raw_affiliation_strings":["Department of Pharmacy, Veterans Affairs Medical Center, Louisville, KY, USA"],"raw_orcid":"https://orcid.org/0000-0003-1550-6509","affiliations":[{"raw_affiliation_string":"Department of Pharmacy, Veterans Affairs Medical Center, Louisville, KY, USA","institution_ids":["https://openalex.org/I2799886695","https://openalex.org/I4210111273"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069133252","display_name":"Jennifer Meyer Reid","orcid":"https://orcid.org/0000-0003-4638-054X","observed_orcids":["https://orcid.org/0000-0003-4638-054X"]},"institutions":[{"id":"https://openalex.org/I2801733747","display_name":"Lexington VA Health Care System","ror":"https://ror.org/01dm04760","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1322918889","https://openalex.org/I2799886695","https://openalex.org/I2801733747","https://openalex.org/I4210112672"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jennifer Meyer Reid","raw_affiliation_strings":["Department of Pharmacy, Veterans Affairs Health Care System, Lexington, KY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacy, Veterans Affairs Health Care System, Lexington, KY, USA","institution_ids":["https://openalex.org/I2801733747"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5084611420","display_name":"Matthew T Lane","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2801733747","display_name":"Lexington VA Health Care System","ror":"https://ror.org/01dm04760","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1322918889","https://openalex.org/I2799886695","https://openalex.org/I2801733747","https://openalex.org/I4210112672"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Matthew Lane","raw_affiliation_strings":["Department of Pharmacy, Veterans Affairs Health Care System, Lexington, KY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacy, Veterans Affairs Health Care System, Lexington, KY, USA","institution_ids":["https://openalex.org/I2801733747"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5017136592"],"corresponding_institution_ids":["https://openalex.org/I2799886695","https://openalex.org/I4210111273"],"apc_list":{"value":4000,"currency":"USD","value_usd":4000},"apc_paid":null,"fwci":2.1179,"has_fulltext":false,"cited_by_count":12,"citation_normalized_percentile":{"value":0.88587857,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":95,"max":98},"biblio":{"volume":"58","issue":"7","first_page":"685","last_page":"689"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9883000254631042,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9883000254631042,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10760","display_name":"Pancreatitis Pathology and Treatment","score":0.009600000455975533,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pancreatitis","display_name":"pancreatitis","score":0.9929999709129333},{"id":"https://openalex.org/keywords/incretin-based-therapy","display_name":"incretin-based therapy","score":0.8190000057220459},{"id":"https://openalex.org/keywords/thiazolidinediones","display_name":"thiazolidinediones","score":0.9020000100135803},{"id":"https://openalex.org/keywords/dpp-4-inhibitors","display_name":"DPP-4 inhibitors","score":0.9319999814033508},{"id":"https://openalex.org/keywords/glp-1-receptor-agonists","display_name":"GLP-1 receptor agonists","score":0.9879999756813049},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9200000166893005},{"id":"https://openalex.org/keywords/pioglitazone","display_name":"pioglitazone","score":0.8579999804496765},{"id":"https://openalex.org/keywords/rosiglitazone","display_name":"rosiglitazone","score":1.0},{"id":"https://openalex.org/keywords/adverse-drug-reactions","display_name":"adverse drug reactions","score":0.7480000257492065},{"id":"https://openalex.org/keywords/veterans","display_name":"veterans","score":0.7599999904632568},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.7960000038146973}],"concepts":[{"id":"https://openalex.org/C2778881409","wikidata":"https://www.wikidata.org/wiki/Q1420402","display_name":"Incretin","level":4,"score":0.8721899390220642},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7486066818237305},{"id":"https://openalex.org/C2780765947","wikidata":"https://www.wikidata.org/wiki/Q12033531","display_name":"Administration (probate law)","level":2,"score":0.6078809499740601},{"id":"https://openalex.org/C2775967933","wikidata":"https://www.wikidata.org/wiki/Q1527888","display_name":"Pancreatitis","level":2,"score":0.5907512903213501},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.4483069181442261},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.38871365785598755},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.36823219060897827},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.3453812301158905},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.18950119614601135},{"id":"https://openalex.org/C17744445","wikidata":"https://www.wikidata.org/wiki/Q36442","display_name":"Political science","level":0,"score":0.1750473976135254},{"id":"https://openalex.org/C199539241","wikidata":"https://www.wikidata.org/wiki/Q7748","display_name":"Law","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000077154","descriptor_name":"Rosiglitazone","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000077205","descriptor_name":"Pioglitazone","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000077205","descriptor_name":"Pioglitazone","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000097789","descriptor_name":"Glucagon-Like Peptide-1 Receptor Agonists","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010195","descriptor_name":"Pancreatitis","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":true},{"descriptor_ui":"D010195","descriptor_name":"Pancreatitis","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":true},{"descriptor_ui":"D012189","descriptor_name":"Retrospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014481","descriptor_name":"United States","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D014493","descriptor_name":"United States Department of Veterans Affairs","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":true},{"descriptor_ui":"D014728","descriptor_name":"Veterans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015331","descriptor_name":"Cohort Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D045162","descriptor_name":"Thiazolidinediones","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D045162","descriptor_name":"Thiazolidinediones","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D054795","descriptor_name":"Incretins","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D054795","descriptor_name":"Incretins","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D054873","descriptor_name":"Dipeptidyl-Peptidase IV Inhibitors","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D054873","descriptor_name":"Dipeptidyl-Peptidase IV Inhibitors","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D054873","descriptor_name":"Dipeptidyl-Peptidase IV Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1177/10600280231205490","doi":"https://doi.org/10.1177/10600280231205490","is_oa":false,"landing_page_url":"https://doi.org/10.1177/10600280231205490","pdf_url":null,"source":{"id":"https://openalex.org/S113426163","display_name":"Annals of Pharmacotherapy","issn_l":"0012-6578","issn":["0012-6578","1060-0280","1542-6270"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of Pharmacotherapy","raw_type":"journal-article"},{"id":"pmid:37881914","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/37881914","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Annals of pharmacotherapy","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":27,"referenced_works":["https://openalex.org/W1913436710","https://openalex.org/W1972516036","https://openalex.org/W2004541371","https://openalex.org/W2077397785","https://openalex.org/W2081932595","https://openalex.org/W2119496770","https://openalex.org/W2124984368","https://openalex.org/W2136259411","https://openalex.org/W2141671776","https://openalex.org/W2144126171","https://openalex.org/W2463960274","https://openalex.org/W2477411371","https://openalex.org/W2611275678","https://openalex.org/W2614450769","https://openalex.org/W2770161112","https://openalex.org/W2785207810","https://openalex.org/W2795857566","https://openalex.org/W2804034649","https://openalex.org/W2885588864","https://openalex.org/W2904780076","https://openalex.org/W2990309084","https://openalex.org/W2992144798","https://openalex.org/W3007158567","https://openalex.org/W3119810912","https://openalex.org/W3120821309","https://openalex.org/W3134327007","https://openalex.org/W3175873987"],"related_works":["https://openalex.org/W2058206834","https://openalex.org/W2314925473","https://openalex.org/W7110542160","https://openalex.org/W1983616459","https://openalex.org/W2550959021","https://openalex.org/W4394423140","https://openalex.org/W4400321068","https://openalex.org/W2124984368","https://openalex.org/W2152211963","https://openalex.org/W4415591132"],"abstract_inverted_index":{"BACKGROUND:":[0],"Incretin":[1],"therapies,":[2],"comprised":[3],"of":[4,24,36,61,69,79,131,136,171,180,192,205,219,245,254,268,300],"the":[5,22,62,77,97,177,223],"dipeptidyl":[6],"peptidase-4":[7],"inhibitors":[8],"(DPP-4i)":[9],"and":[10,46,94,125,150,155,159,225,259],"glucagon-like":[11],"peptide-1":[12],"receptor":[13],"agonists":[14],"(GLP-1":[15],"RAs),":[16],"have":[17,31],"been":[18],"increasingly":[19],"utilized":[20],"for":[21],"treatment":[23],"type":[25],"2":[26],"diabetes":[27],"(T2DM).":[28],"Previous":[29],"studies":[30],"conflicting":[32],"results":[33],"regarding":[34],"risk":[35,45,299],"pancreatitis":[37,81,132,189,220,255,269],"associated":[38,66,295],"with":[39,67,84,111,176,277,296],"these":[40],"agents-some":[41],"suggest":[42],"an":[43,87,115,160,260,273,297],"increased":[44,298],"others":[47],"find":[48],"no":[49,216,265],"correlation.":[50],"Adverse":[51],"event":[52],"reporting":[53],"systems":[54],"indicate":[55],"that":[56,287],"incretin":[57,88,116,178,199,226,274,288],"therapies":[58,289],"are":[59],"some":[60],"most":[63],"common":[64],"drugs":[65],"reports":[68],"pancreatitis.":[70,302],"OBJECTIVES:":[71],"This":[72,103,241,281],"study":[73,108,244],"aimed":[74],"to":[75,284,293],"compare":[76],"odds":[78,162,213,229,262],"developing":[80,301],"in":[82,256,270],"veterans":[83,110],"T2DM":[85,112],"prescribed":[86,114,138,272],"therapy":[89,117,140,275],"versus":[90],"thiazolidinediones":[91],"(TZDs:":[92],"pioglitazone":[93],"rosiglitazone)":[95],"within":[96,133],"Veterans":[98],"Health":[99],"Administration":[100],"(VHA).":[101],"METHODS:":[102],"was":[104,141,148,164],"a":[105,119,144,188,202,250,278],"retrospective":[106,242],"cohort":[107,169,179,186,200,243],"analyzing":[109],"first":[113],"or":[118],"TZD":[120,168,185,224],"between":[121,222],"January":[122],"1,":[123],"2011,":[124],"December":[126],"31,":[127],"2021.":[128],"A":[129],"diagnosis":[130],"365":[134],"days":[135],"being":[137],"either":[139],"counted":[142],"as":[143],"positive":[145],"case.":[146],"Data":[147],"collected":[149],"analyzed":[151],"utilizing":[152],"VA's":[153],"Informatics":[154],"Computing":[156],"Infrastructure":[157],"(VINCI)":[158],"adjusted":[161,212,261],"ratio":[163,214,230,263],"calculated.":[165],"RESULTS:":[166],"The":[167,184,198],"consisted":[170],"42":[172],"912":[173],"patients":[174,271],"compared":[175,276],"304":[181],"811":[182],"patients.":[183,197,210],"had":[187,201],"incidence":[190,203,253],"rate":[191,204],"1.94":[193],"cases":[194,207,221],"per":[195,208],"1000":[196,209],"2.06":[206],"An":[211],"found":[215,249,264],"statistical":[217,266],"difference":[218,267],"cohorts":[227],"(adjusted":[228],"[AOR]":[231],"=":[232],"0.94,":[233],"95%":[234],"CI":[235],"[0.75,":[236],"1.18]).":[237],"CONCLUSION":[238],"AND":[239],"RELEVANCE:":[240],"national":[246],"VHA":[247],"data":[248,282],"relatively":[251],"low":[252],"both":[257],"cohorts,":[258],"control":[279],"group.":[280],"adds":[283],"growing":[285],"evidence":[286],"do":[290],"not":[291],"seem":[292],"be":[294]},"counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":6},{"year":2024,"cited_by_count":3}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2023-10-27T00:00:00"}